NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Vivo Capital’

21 May 2014

KKR joins investors in biotherapeutics developer Coherus BioSciences

Coherus BioSciences, a US biologics platform company focused on biosimilars, has closed a Series C round raising $55m from investors including KKR, Venrock, RA Capital Management, Rock Springs Capital and Fidelity Biosciences.

22 April 2014

Vivo Capital leads $58.5m Series D for ProNAi Therapeutics

biotech_lrg Nucleic acid therapeutics developer ProNAi Therapeutics has secured $59.5m in a Series D round led by venture capital firm Vivo Capital.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014